MoneyWorks4Me

Piramal Pharma informs about conference call

29 Apr 2025 Evaluate
Pursuant to Regulation 30(6) of the Listing Regulations, Piramal Pharma has informed that it enclosed the details of the Conference Call with investors/ analysts.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1846.80
Dr. Reddys Labs. 1228.60
Cipla 1390.60
Lupin 2069.80
Zydus Lifesciences 1216.00
View more..